Nautiyal, Jyoti <br/><br/>
Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.  [electronic resource] 

 -  International journal of cancer  Feb 2011 
 - 951-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.25410  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--drug therapy<br/>Adenomatous Polyposis Coli Protein--physiology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Blotting, Western<br/>CSK Tyrosine-Protein Kinase<br/>Cell Adhesion<br/>Cell Movement<br/>Cell Proliferation--drug effects<br/>Cell Transformation, Neoplastic--drug effects<br/>Cells, Cultured<br/>Colonic Neoplasms--drug therapy<br/>Curcumin--pharmacology<br/>Dasatinib<br/>Drug Synergism<br/>Electrophoretic Mobility Shift Assay<br/>Endothelium, Vascular--cytology<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Intestinal Neoplasms--drug therapy<br/>Mice<br/>Mice, Knockout<br/>NF-kappa B--genetics<br/>Neoplasm Invasiveness<br/>Neovascularization, Pathologic<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--metabolism<br/>Pyrimidines--pharmacology<br/>RNA, Messenger--genetics<br/>Receptor, IGF Type 1--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thiazoles--pharmacology<br/>Umbilical Veins--cytology<br/>src-Family Kinases